Form 8-K - Current report:
SEC Accession No. 0001193125-25-262610
Filing Date
2025-11-03
Accepted
2025-11-03 16:23:34
Documents
10
Period of Report
2025-10-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K acad-20251028.htm   iXBRL 8-K 45462
  Complete submission text file 0001193125-25-262610.txt   152244

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20251028.xsd EX-101.SCH 26217
12 EXTRACTED XBRL INSTANCE DOCUMENT acad-20251028_htm.xml XML 4760
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 251444452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)